Jones, Mary Beth

A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)

Ravandi, F., Gojo, I., Patnaik, M. M., Minden, M. D., Kantarjian, H., Johnson-Levonas, A. O., Fancourt, C., Lam, R., Jones, M. B., Knox, C. D., et al. (2016) · Leukemia Research

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 57

Evaluating machine learning algorithms estimating tremor severity ratings on the Bain–Findley scale

Yohanandan, S. A. C., Jones, M., Peppard, R., Tan, J. L., McDermott, H. J., & Perera, T. (2016) · Measurement Science and Technology

Deep Brain Stimulation and Movement DisordersArtificial Intelligence in Healthcare

Cited by 8